Is healthy sugar possible — and would you eat it?

Israeli food-tech company DouxMatok (Hebrew for "double sweet") has created a sugary product that uses 40 percent less actual sugar yet still tastes sweet.

Photo: pixel-shot / Adobe Stock
  • Consumers are fed a lot of nonsense about sugar and fad diets.
  • Our bodies must consume sugar; the question is how much and in what form.
  • Companies are trying to develop healthier sugars to combat our "sugar addiction."
Keep reading Show less

VR experiments manipulate how people feel about coffee

A new study looks at how images of coffee's origins affect the perception of its premiumness and quality.

Credit: Escobar / Petit / Velasco, Frontiers in Psychology
  • Images can affect how people perceive the quality of a product.
  • In a new study, researchers show using virtual reality that images of farms positively influence the subjects' experience of coffee.
  • The results provide insights on the psychology and power of marketing.
Keep reading Show less

New study suggests placebo might be as powerful as psychedelics

New study suggests the placebo effect can be as powerful as microdosing LSD.

Credit: agsandrew / Adobe Stock
  • New research from Imperial College London investigated the psychological effects of microdosing LSD in 191 volunteers.
  • While microdosers experienced beneficial mental health effects, the placebo group performed statistically similar to those who took LSD.
  • Researchers believe the expectation of a trip could produce some of the same sensations as actually ingesting psychedelics.
Keep reading Show less

The secret life of maladaptive daydreaming

Daydreaming can be a pleasant pastime, but people who suffer from maladaptive daydreaming are trapped by their fantasies.

Credit: Wikimedia Commons
  • Maladaptive daydreamers can experience intricate, vivid daydreams for hours a day.
  • This addiction can result in disassociation from vital life tasks and relationships.
  • Psychologists, online communities, and social pipelines are spreading awareness and hope for many.
  • Keep reading Show less

    Chemists modify hallucinogen to treat depression and addiction

    A new study explores the therapeutic potential of the psychedelic drug ibogaine, which has been used in Africa for centuries.

    Credit: David S. Soriano / Wikimedia Commons
    • For decades, people have reported that the psychedelic drug ibogaine seems to rid addicts of their cravings for drugs.
    • In a new study, researchers created a variant of ibogaine that's less toxic and doesn't cause hallucinations.
    • The results showed that the variant seemed to significantly lower depression and drug relapse rates in tests on mice.
    Keep reading Show less
    Quantcast